Stockchase Opinions

Jim Cramer - Mad Money Waters Corp WAT-N PARTIAL BUY Feb 22, 2023

Life sciences suffered post-Covid after rallying during Covid. WAT is a major player. Last Wednesday they reperted a clean top/bottom line beat, but issued a cautious earnings forecast, so the market gave a muted reaction. Likes them, because they have few competitors at at time when the economy is slowing down.

N/A

Stock price when the opinion was issued

electrical electronic
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

DON'T BUY

WAT vs. TMO vs. DHR Not performing as well as Thermo Fisher or Danaher. Cash from operations has been flat in the last 4 years, whereas the other two have doubled, which is reflected in the stock price. Market share, operating margins, and pricing power impact the business model. Compare these when assessing competitors in an industry.

BUY
After years of stagnation, WAT brought in a new CEO in Sept. 2020. It nearly doubled in the next 12 months, then pulled back a lot. WAT assists drug and biotech companies, businesses he likes that are putting up excellent quarters.